Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
This study has been completed.
Study NCT00490945   Information provided by Vanda Pharmaceuticals
First Received: June 22, 2007   Last Updated: February 26, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Circadian Rhythm Sleep Disorders
Additional conditions recognized in this trial
Sleep Disorders
Sleep Disorders, Circadian Rhythm
More general conditions related to this trial
Chronobiology Disorders
Disorders of Environmental Origin
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurologic Manifestations
Occupational Diseases
Signs and Symptoms
Interventions listed in this trial
VEC-162
Sponsors listed in this trial
Vanda Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services